Kazia Therapeutics ADR buy Langfinger
Start price
19.11.20
/
50%
€10.50
Target price
19.11.21
-
Performance (%)
-28.57%
End price
19.11.21
-
Summary
This prediction is currently being closed. The prediction for Kazia Therapeutics ADR disappoints with a performance of -28.57%. Langfinger has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kazia Therapeutics ADR | - | - | - | - |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % | 53,20 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % | 91,09 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % | 63,93 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % | 64,84 % |
According to Langfinger what are the pros and cons of Kazia Therapeutics ADR for the foreseeable future?
Pros
Cons
Risky Investment
Comments by Langfinger for this prediction
In the thread Kazia Therapeutics ADR diskutieren
Buy Kazia Therapeutics ADR